SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000930413-08-002957
Filing Date
2008-05-09
Accepted
2008-05-09 09:38:42
Documents
1
Period of Report
2008-06-10
Effectiveness Date
2008-05-09

Document Format Files

Seq Description Document Type Size
1 c53346.txt DEF 14A 165954
  Complete submission text file 0000930413-08-002957.txt   167415
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /DE/ (Filer) CIK: 0001053369 (see all company filings)

IRS No.: 223542636 | State of Incorp.: DE | Fiscal Year End: 0331
Type: DEF 14A | Act: 34 | File No.: 001-15697 | Film No.: 08816258
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1